358 related articles for article (PubMed ID: 18423577)
21. Role of BDNF Val66Met functional polymorphism in Alzheimer's disease-related depression.
Borroni B; Archetti S; Costanzi C; Grassi M; Ferrari M; Radeghieri A; Caimi L; Caltagirone C; Di Luca M; Padovani A;
Neurobiol Aging; 2009 Sep; 30(9):1406-12. PubMed ID: 18179845
[TBL] [Abstract][Full Text] [Related]
22. Beta1- and beta2-adrenergic receptor polymorphisms affect susceptibility to idiopathic dilated cardiomyopathy.
Forleo C; Sorrentino S; Guida P; Romito R; De Tommasi E; Iacoviello M; Pitzalis M
J Cardiovasc Med (Hagerstown); 2007 Aug; 8(8):589-95. PubMed ID: 17667029
[TBL] [Abstract][Full Text] [Related]
23. Association study and meta-analysis of Alzheimer's disease risk and presenilin-1 intronic polymorphism.
Rodríguez-Manotas M; Amorín-Díaz M; Cañizares-Hernández F; Ruíz-Espejo F; Martínez-Vidal S; González-Sarmiento R; Martínez-Hernández P; Cabezas-Herrera J
Brain Res; 2007 Sep; 1170():119-28. PubMed ID: 17719017
[TBL] [Abstract][Full Text] [Related]
24. Allele epsilon 4 of APOE is a stronger predictor of Alzheimer risk in Sicily than in continental South Italy.
Bosco P; Guéant-Rodríguez RM; Anello G; Spada RS; Romano A; Caraci F; Ferri R; Guéant JL
Neurosci Lett; 2005 Nov; 388(3):168-72. PubMed ID: 16040191
[TBL] [Abstract][Full Text] [Related]
25. Polymorphism of the regulatory region of the presenilin-2 gene in sporadic Alzheimer's disease: a case-control study.
Quan W; Yasuda M; Hashimoto M; Yamamoto Y; Ishii K; Kazui H; Mori E; Kakigi T; Maeda K
J Neurol Sci; 2006 Jan; 240(1-2):71-5. PubMed ID: 16233903
[TBL] [Abstract][Full Text] [Related]
26. Association of beta2 adrenergic receptor polymorphisms and related haplotypes with triglyceride and LDL-cholesterol levels.
Petrone A; Zavarella S; Iacobellis G; Zampetti S; Vania A; Di Pietro S; Galgani A; Leonetti F; Di Mario U; Buzzetti R
Eur J Hum Genet; 2006 Jan; 14(1):94-100. PubMed ID: 16251889
[TBL] [Abstract][Full Text] [Related]
27. Association between promoter polymorphisms of vascular endothelial growth factor gene and sporadic Alzheimer's disease among Northern Chinese Han.
Yuan Q; Zuo X; Jia J
Neurosci Lett; 2009 Jul; 457(3):133-6. PubMed ID: 19429179
[TBL] [Abstract][Full Text] [Related]
28. Interleukin-10 and interleukin-6 gene polymorphisms as risk factors for Alzheimer's disease.
Arosio B; Trabattoni D; Galimberti L; Bucciarelli P; Fasano F; Calabresi C; Cazzullo CL; Vergani C; Annoni G; Clerici M
Neurobiol Aging; 2004 Sep; 25(8):1009-15. PubMed ID: 15212825
[TBL] [Abstract][Full Text] [Related]
29. Increased frequency of positive family history of dementia in sporadic CJD.
Krasnianski A; von Ahsen N; Heinemann U; Meissner B; Schulz-Schaeffer WJ; Kretzschmar HA; Armstrong VW; Zerr I
Neurobiol Aging; 2009 Apr; 30(4):615-21. PubMed ID: 17822808
[TBL] [Abstract][Full Text] [Related]
30. Case-control study of vascular endothelial growth factor (VEGF) genetic variability in Alzheimer's disease.
Mateo I; Llorca J; Infante J; Rodríguez-Rodríguez E; Sánchez-Quintana C; Sánchez-Juan P; Berciano J; Combarros O
Neurosci Lett; 2006 Jun; 401(1-2):171-3. PubMed ID: 16569480
[TBL] [Abstract][Full Text] [Related]
31. Association between presenilin 1 intronic polymorphism and late onset Alzheimer's disease in the North Chinese population.
Jia L; Zhou C; Lv H; Wang W; Ye J; Zhang X; Zhou W; Xu J; Wang L; Jia J
Brain Res; 2006 Oct; 1116(1):201-5. PubMed ID: 16938285
[TBL] [Abstract][Full Text] [Related]
32. Allelic expression of APOE in human brain: effects of epsilon status and promoter haplotypes.
Bray NJ; Jehu L; Moskvina V; Buxbaum JD; Dracheva S; Haroutunian V; Williams J; Buckland PR; Owen MJ; O'Donovan MC
Hum Mol Genet; 2004 Nov; 13(22):2885-92. PubMed ID: 15385439
[TBL] [Abstract][Full Text] [Related]
33. Differential CSF butyrylcholinesterase levels in Alzheimer's disease patients with the ApoE epsilon4 allele, in relation to cognitive function and cerebral glucose metabolism.
Darreh-Shori T; Brimijoin S; Kadir A; Almkvist O; Nordberg A
Neurobiol Dis; 2006 Nov; 24(2):326-33. PubMed ID: 16973370
[TBL] [Abstract][Full Text] [Related]
34. Three SNPs in the GSTO1, GSTO2 and PRSS11 genes on chromosome 10 are not associated with age-at-onset of Alzheimer's disease.
Ozturk A; Desai PP; Minster RL; Dekosky ST; Kamboh MI
Neurobiol Aging; 2005; 26(8):1161-5. PubMed ID: 15917099
[TBL] [Abstract][Full Text] [Related]
35. Lack of association between Interleukin-18 gene promoter polymorphisms and onset of Alzheimer's disease.
Segat L; Milanese M; Arosio B; Vergani C; Crovella S
Neurobiol Aging; 2010 Jan; 31(1):162-4. PubMed ID: 18433937
[TBL] [Abstract][Full Text] [Related]
36. Important differences between human and mouse APOE gene promoters: limitation of mouse APOE model in studying Alzheimer's disease.
Maloney B; Ge YW; Alley GM; Lahiri DK
J Neurochem; 2007 Nov; 103(3):1237-57. PubMed ID: 17854398
[TBL] [Abstract][Full Text] [Related]
37. beta2-Adrenergic receptor gene variations associated with stage-2 hypertension in northern Han Chinese.
Ge D; Huang J; He J; Li B; Duan X; Chen R; Gu D
Ann Hum Genet; 2005 Jan; 69(Pt 1):36-44. PubMed ID: 15638826
[TBL] [Abstract][Full Text] [Related]
38. The PPAR-alpha gene in Alzheimer's disease: lack of replication of earlier association.
Sjölander A; Minthon L; Bogdanovic N; Wallin A; Zetterberg H; Blennow K
Neurobiol Aging; 2009 Apr; 30(4):666-8. PubMed ID: 17850927
[TBL] [Abstract][Full Text] [Related]
39. Interaction of CTSD and A2M polymorphisms in the risk for Alzheimer's disease.
Mariani E; Seripa D; Ingegni T; Nocentini G; Mangialasche F; Ercolani S; Cherubini A; Metastasio A; Pilotto A; Senin U; Mecocci P
J Neurol Sci; 2006 Sep; 247(2):187-91. PubMed ID: 16784755
[TBL] [Abstract][Full Text] [Related]
40. Myocyte enhancing factor-2A in Alzheimer's disease: genetic analysis and association with MEF2A-polymorphisms.
González P; Alvarez V; Menéndez M; Lahoz CH; Martínez C; Corao AI; Calatayud MT; Peña J; García-Castro M; Coto E
Neurosci Lett; 2007 Jan; 411(1):47-51. PubMed ID: 17112666
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
